Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer

BMC Cancer

Volumn 5, Issue , 2005, Pages

  El Saghir, Nagi S ^a   Otrock, Zaher K ^a   Bleik, Jamal H ^b  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b LEBANESE UNIVERSITY   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; EYE DROPS; PARACETAMOL; PREDNISONE; SODIUM CHLORIDE; ZOLEDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; IMIDAZOLE DERIVATIVE;

ADULT; ANTERIOR EYE CHAMBER; ARTICLE; BREAST CANCER; CASE REPORT; CATARACT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG EFFICACY; DRUG INFUSION; FEMALE; HUMAN; INTRAOCULAR PRESSURE; IRIDOCYCLITIS; LENS IMPLANT; MEDICAL DOCUMENTATION; MEDICAL SPECIALIST; POSTMENOPAUSE OSTEOPOROSIS; SLIT LAMP; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT REFUSAL; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; OSTEOPOROSIS;

BONE DENSITY CONSERVATION AGENTS; BREAST NEOPLASMS; DIPHOSPHONATES; FEMALE; HUMANS; IMIDAZOLES; MIDDLE AGED; OSTEOPOROSIS; UVEITIS, ANTERIOR;

EID: 29244475715     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-5-156     Document Type: Article

References (13)

1. Robertson WG, Morgan DB, Fleisch H, Francis MD: The effects of diphosphonates on the exchangeable and non-exchangeable calcium and phosphate of hydroxyapatite. Biochim Biophys Acta 1971, 261:517-525.
2. Conte P, Guarneri V: Safety of intravenous and oral bisphosphonates and compliance with dosing regimens. Oncologist 2004, S28-37 (suppl 4).
3. Mbekeani JN, Slamovits TL, Schwartz BH, Sauer HL: Ocular inflammation associated with alendronate therapy. Arch Ophthalmol 1999, 117:837-838.
4. Salmen S, Berrueta L, Sanchez N, Montes H, Borges L: Nongranulomatous anterior uveitis associated with alendronate therapy. Invest Clin 2002, 43:49-52.
5. Malik AR, Campbell SH, Toma NM: Bilateral acute anterior uveitis after alendronate. Br J Ophthalmol 2002, 86:1443.
6. Ghose K, Waterworth R, Trolove P, Highton J: Uveitis associated with pamidronate. Aust N Z J Med 1994, 24:320.
7. Rey J, Daumen-Legre V, Pham T, Bernard P, Dahan L, Acquaviva PC, Lafforgue P: Uveitis, an under-recognized adverse effect of pamidronate. Case report and literature review. Joint Bone Spine 2000, 67:337-340.
8. Fraunfelder FW, Fraunfelder FT, Jensvold B: Scleritis and other ocular side effects associated with pamidronate disodium. Am J Ophthalmol 2003, 135:219-222.
9. Durnian JM, Olujohungbe A, Kyle G: Bilateral acute uveitis and conjunctivitis after zoledronic acid therapy. Eye 2005, 19:221-222.
10. Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ, Castiglione M, Tu D, Shepherd LE, Pritchard KI, Livingston RB, Davidson NE, Norton L, Perez EA, Abrams JS, Therasse P, Palmer MJ, Pater JL: A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 2003, 349:1793-1802.
11. Reid IR. Bisphosphonates: new indications and methods of administration: Curr Opin Rheumatol 2003, 15:458-463.
12. Emery J. Capsular opacification after cataract surgery: Curr Opin Ophthalmol 1999, 10:73-80.
13. Fietta P, Manganelli P, Lodigiani L: Clodronate induced uveitis. Ann Rheum Dis 2003, 62:378.